The University of Chicago Header Logo

Connection

Olwen Hahn to Quinazolines

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Quinazolines.
Olwen Hahn
Connection Strength
0.180
Quinazolines
  1. Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial). Eur J Cancer. 2021 08; 153:223-233.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.